These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6297672)

  • 1. Recovery of function after mesotelencephalic dopaminergic injury in senescence.
    Marshall JF; Drew MC; Neve KA
    Brain Res; 1983 Jan; 259(2):249-60. PubMed ID: 6297672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neostriatal dopamine and sensory inattention.
    Marshall JF; Berrios N; Sawyer S
    J Comp Physiol Psychol; 1980 Oct; 94(5):833-46. PubMed ID: 6968761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR; Neve KA; Grisham JE; Marshall JF
    Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.
    Neve KA; Kozlowski MR; Marshall JF
    Brain Res; 1982 Jul; 244(1):33-44. PubMed ID: 6288182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of function and basal ganglia [14C]2-deoxyglucose uptake after nigrostriatal injury.
    Kozlowski MR; Marshall JF
    Brain Res; 1983 Jan; 259(2):237-48. PubMed ID: 6297671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered succinate dehydrogenase activity of basal ganglia following to mesotelencephalic dopaminergic projection.
    Marshall JF; Critchfield JW; Kozlowski MR
    Brain Res; 1981 May; 212(2):367-77. PubMed ID: 7225874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat.
    Hirschhorn ID; Makman MH; Sharpless NS
    Brain Res; 1982 Feb; 234(2):357-68. PubMed ID: 7199364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment.
    Rebec GV; Lee EH
    Brain Res; 1982 Oct; 250(1):188-92. PubMed ID: 7139316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and biochemical evidence of apomorphine-induced supersensitivity of the striatal dopamine receptors.
    Deshaies P; Bédard P; Falardeau P; Di Paolo T
    Neuropharmacology; 1984 Oct; 23(10):1219-22. PubMed ID: 6521857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of forebrain lesions in the neonatal rat: survival of midbrain dopaminergic neurons and the crossed nigrostriatal projection.
    Jaeger CB; Joh TH; Reis DJ
    J Comp Neurol; 1983 Jul; 218(1):74-90. PubMed ID: 6886067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control.
    Marshall JF
    Brain Res; 1979 Nov; 177(2):311-24. PubMed ID: 574052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats.
    Heikkila RE; Shapiro BS; Duvoisin RC
    Brain Res; 1981 May; 211(2):285-92. PubMed ID: 7237124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nomifensine on the toxicity of 6-hydroxydopamine for mesotelencephalic dopamine neurons.
    Lees GJ; Kydd RR; Horsburgh RJ; Wright JJ
    Brain Res; 1984 Aug; 308(1):155-8. PubMed ID: 6434148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral frontal cortex ablation producing neglect causes time-dependent changes in striatal glutamate receptors.
    Vargo JM; Marshall JF
    Behav Brain Res; 1996 May; 77(1-2):189-99. PubMed ID: 8762170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade.
    Neve KA; Loeschen S; Marshall JF
    Brain Res; 1985 Mar; 329(1-2):225-31. PubMed ID: 3156659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.